Abstract
Alternating chemoradiotherapy was performed in 35 patients with locally advanced nasopharyngeal cancer. The median duration of follow-up was 20 months, and the 2-year progression free and overall survival rates were 83% (95% confidence interval: 66~101%) and 94% (95% CI: 84~105%), respectively. This method may be useful in treating nasopharyngeal cancer.
Publication types
-
Clinical Trial
-
Clinical Trial, Phase II
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / pathology
-
Adenocarcinoma / radiotherapy*
-
Adolescent
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cisplatin / administration & dosage
-
Cisplatin / adverse effects
-
Female
-
Fluorouracil / administration & dosage
-
Fluorouracil / adverse effects
-
Follow-Up Studies
-
Humans
-
Male
-
Middle Aged
-
Nasopharyngeal Neoplasms / drug therapy*
-
Nasopharyngeal Neoplasms / pathology
-
Nasopharyngeal Neoplasms / radiotherapy*
-
Radiotherapy Dosage
-
Survival Rate